Table 2.
Patient characteristics and risk factors related to skin tears in the prevalence study
| Patients with skin tear (n = 16) | Patients without skin tear (n = 394) | P value | |
|---|---|---|---|
| Age (years) | 92·5 (84·0–94·5) | 87 (81·0–92·0) | 0·085 |
| Gender | |||
| Male | 4 (25.0) | 106 (26·9) | 1 |
| Female | 12 (75.0) | 288 (73·1) | |
| Hospitalisation (years) | 3 (0–5) | 2 (0–4) | 0·260 |
| Braden Scale | |||
| Total score | 11·5 (10·5–12) | 12 (11–13) | 0·331 |
| Sensory perception | 3 (2·5–3) | 3 (2–3) | 0·756 |
| Moisture | 2 (1·5–3·0) | 2 (2–3) | 0·874 |
| Activity | 1 (1–2) | 1 (1–2) | 0·918 |
| Mobility | 2 (2–2) | 2 (1–2) | 0·949 |
| Nutrition | 3 (1·5–3) | 3 (3–3) | 0·066 |
| Friction and shear | 1 (1–1) | 1 (1–1) | 0·087 |
| Body mass index | 17·5 (16·3–19·4) | 17·4 (15·0–19·6) | 0·828 |
| Immobility | 15 (93·8) | 333 (84·5) | 0·485 |
| Paralysis | 4 (25.0) | 104 (26·4) | 1.000 |
| Contracture of the arm | 11 (68·8) | 266 (67·5) | 1.000 |
| Contracture of the leg | 12 (75.0) | 296 (75·1) | 1.000 |
| Polypharmacy* | 10 (62·5) | 170 (43·2) | 0·198 |
| Corticosteroid use | 1 (6·3) | 10 (2·5) | 0·358 |
| Anticoagulant agent | 7 (43·8) | 90 (22·8) | 0·070 |
| Underlying disease | |||
| Cerebrovascular disease | 12 (75.0) | 290 (73·6) | 0·432 |
| Cardiac disease | 3 (18·7) | 26 (6·6) | |
| Dementia | 0 (0·0) | 31 (7·9) | |
| Parkinson disease | 0 (0·0) | 14 (3·6) | |
| Disuse syndrome | 0 (0·0) | 11 (2·8) | |
| Malignant neoplasm | 0 (0·0) | 7 (1·8) | |
| Others | 1 (6·3) | 15 (3·7) |
Values are medians (first quartiles and third quartiles) or number of patients (%). Differences in interval variables were assessed using a Wilcoxon rank sum test. Differences in categorical variables were assessed using a chi‐square test or Fisher's exact probability test.
*
Polypharmacy; over five medicines of internal use per oral or gastrosoma, nasal tube.